R Andrew Eckert

R Andrew Eckert is a seasoned executive with extensive experience in leadership roles across multiple companies. Currently serving as a Member of the Board of Directors at Vantive and BD, R Andrew Eckert also holds positions as Senior Advisor at Permira and Executive Chairman at Kipu Health. Previous roles include Lead Director at Fortrea, Chief Executive Officer at Zelis and KCI an Acelity Company, and Chairman of the Board of Directors at Varian, which was sold to Siemens Healthineers for $17 billion in 2021. R Andrew Eckert has a strong educational background with a BS in Industrial Engineering and an MBA from Stanford University.